Part A MACs shall deny Q5106 when billed with modifier EA ESA, anemia, chemo-induced for anemia secondary to myelosuppressive anticancer chemotherapy in solid tumors, multiple myeloma, lymphoma, and lymphocytic leukemia when a hemoglobin 10.0g/dL or greater or hematocrit 30.0% or greater is reported
Semaglutide is a GLP-1 receptor agonist
Baumgard, PhD, Iowa State University, for providing his expertise and reviewing the final paper, and Alice Mac-Gregor Harvey, NC State College of Veterinary Medicine, for the graphical illustrations in this text
1 Even in darkness, the retina consumes large amounts of oxygen-often more than it does in light-making it particularly vulnerable to oxidative damage